Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia-Reference-Cited by-同舟云学术

Variants in the APOA5 gene region and the response to combination therapy with statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia

Published:2011-12 Issue:2 Volume:219 Page:737-742
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Brautbar Ariel,Covarrubias Daniel,Belmont John,Lara-Garduno Fremiet,Virani Salim S.,Jones Peter H.,Leal Suzanne M.,Ballantyne Christie M.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Effects of combination lipid therapy in type 2 diabetes mellitus;Ginsberg;N Engl J Med,2010

2. Effects of fenofibrate treatment on cardiovascular disease risk in 9795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study;Scott;Diabetes Care,2009

3. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial;Keech;Lancet,2005

4. Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study;Lai;Arterioscler Thromb Vasc Biol,2007

5. ApolipoproteinB genetic variants modify the response to fenofibrate: a GOLDN study;Wojczynski;J Lipid Res,2010

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of Cardiovascular Drugs for Atherothrombotic, Thromboembolic and Atherosclerotic Risk;Genes;2023-11-09

2. Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety;Personalized Medicine;2022-11-23

3. Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine;Frontiers in Pharmacology;2022-08-12

4. Polymorphisms of the 11q23.3 Locus Affect the Risk and Mortality of Coronary Artery Disease;Journal of Clinical Medicine;2022-08-03

5. Polymorphism rs10105606 of LPL as a Novel Risk Factor for Microalbuminuria;Journal of Inflammation Research;2021-12